Ana Navarro, co-host of the ABC daytime talk show "The View," has publicly confirmed her use of weight loss injections, a significant development following years of public speculation about her transformed physique. Navarro, 54, alluded to her use of GLP-1 medications, such as Mounjaro, during the September 8 episode of the show, which marked the premiere of its 30th season.
During a segment where hosts revisited past show moments, Navarro commented on her appearance in older clips, stating, "Those were all pre-Mounjaro [clips]. We've lost the equivalent of a baby hippo on this table." This remark indirectly confirmed the use of the drugs that have gained widespread popularity as weight-loss tools since their initial development for type 2 diabetes treatment.
Navarro's weight loss journey has been noticeable in recent years, prompting inquiries about her methods. In 2023, she previously denied using Ozempic in response to an Instagram comment. At that time, she explained that her mother's death in 2021 from diabetes-related kidney disease had motivated her to prioritize her health. She recounted a wellness retreat in Mexico in August 2021 with friends, where she focused on healthier cooking, lifestyle changes, and increased physical activity. Upon returning to Miami, they were determined to maintain their healthy habits.
Navarro also stated that she sought professional guidance, including a nutritionist, Pilates coach, pickleball coach, and medical supervision, and was losing between four to five pounds per month at that point.
Navarro is not the only "The View" co-host to discuss using GLP-1 medications. Joy Behar revealed in February that she had lost 25 pounds using the drug. Whoopi Goldberg, 70, also admitted to taking a weight loss medication in a 2024 episode, explaining it was the only treatment that worked for her after trying steroids and other aids. Sunny Hostin, 57, shared that she used Mounjaro to address weight gain experienced during the COVID-19 pandemic, noting she had gained 40 pounds and received negative feedback for her confession.
According to a November poll by KFF, approximately one in eight adults in the United States report currently taking these medications.